Literature DB >> 10074787

Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors.

M Thibonnier1, L N Berti-Mattera, N Dulin, D M Conarty, R Mattera.   

Abstract

Vasopressin (VP) and oxytocin (OT) are cyclic nonapeptides whose actions are mediated by stimulation of specific G protein-coupled receptors (GPCRs) currently classified into V1-vascular (V1R), V2-renal (V2R) and V3-pituitary (V3R) VP receptors and OT receptors (OTR). The recent cloning of the different members of the VP/OT family of receptors now allows the extensive characterization of the molecular determinants involved in ligand binding and signal transduction pathways coupled to a given VP/OT receptor subtype in stably transfected mammalian cell lines. In this article, we review the present knowledge of the signal transduction pathways coupled to the different VP/OT receptor subtypes and we present new observations derived from the study of each human VP or OT receptor subtype stably expressed in CHO cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10074787     DOI: 10.1016/s0079-6123(08)61568-x

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  15 in total

1.  Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.

Authors:  Cristiana Griffante; Andrew Green; Ornella Curcuruto; Carl P Haslam; Bryony A Dickinson; Roberto Arban
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Oxytocin retrogradely inhibits evoked, but not miniature, EPSCs in the rat supraoptic nucleus: role of N- and P/Q-type calcium channels.

Authors:  M Hirasawa; S B Kombian; Q J Pittman
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

3.  Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells.

Authors:  Tran D N Tran; Shaomian Yao; Walter H Hsu; Jeffrey M Gimble; Bruce A Bunnell; Henrique Cheng
Journal:  Mol Cell Endocrinol       Date:  2015-02-16       Impact factor: 4.102

4.  Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse.

Authors:  Ara Schorscher-Petcu; Susana Sotocinal; Sorana Ciura; Anouk Dupré; Jennifer Ritchie; Robert E Sorge; Jacqueline N Crawley; Shuang-Bao Hu; Katsuhiko Nishimori; Larry J Young; Eliane Tribollet; Rémi Quirion; Jeffrey S Mogil
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

5.  A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells.

Authors:  Dandan Dou; Yuge Ji; Junjie Zheng; Jingxin Li; Xiaolong Zhu; Shuhai Tang; Hongjuan Wang; Qin Li; Haiyan Jing
Journal:  Dig Dis Sci       Date:  2021-11-09       Impact factor: 3.487

6.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

7.  An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.

Authors:  Werner G Purschke; Dirk Eulberg; Klaus Buchner; Stefan Vonhoff; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-17       Impact factor: 11.205

Review 8.  Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects.

Authors:  Mariana Rae; Mariana Lemos Duarte; Ivone Gomes; Rosana Camarini; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2021-05-21       Impact factor: 9.473

9.  The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human.

Authors:  Bodil Ohlsson; Ola Björgell; Olle Ekberg; Gassan Darwiche
Journal:  BMC Gastroenterol       Date:  2006-03-16       Impact factor: 3.067

Review 10.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.